Cecilia Catellani

675 total citations
17 papers, 300 citations indexed

About

Cecilia Catellani is a scholar working on Cancer Research, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Cecilia Catellani has authored 17 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Reproductive Medicine and 5 papers in Molecular Biology. Recurrent topics in Cecilia Catellani's work include MicroRNA in disease regulation (7 papers), Ovarian function and disorders (6 papers) and Cancer-related molecular mechanisms research (4 papers). Cecilia Catellani is often cited by papers focused on MicroRNA in disease regulation (7 papers), Ovarian function and disorders (6 papers) and Cancer-related molecular mechanisms research (4 papers). Cecilia Catellani collaborates with scholars based in Italy and Belgium. Cecilia Catellani's co-authors include Maria Elisabeth Street, Chiara Sartori, Francesca Cirillo, Pietro Lazzeroni, Sergio Amarri, Alessia Nicoli, Giovanni Battista La Sala, Sabrina Angelini, Gloria Ravegnini and Gabriele Tridenti and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Cytokine & Growth Factor Reviews.

In The Last Decade

Cecilia Catellani

15 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Catellani Italy 9 100 97 93 61 47 17 300
Seyed Sobhan Bahreiny Iran 12 120 1.2× 71 0.7× 40 0.4× 41 0.7× 57 1.2× 28 346
José L. San‐Millán Spain 9 152 1.5× 228 2.4× 118 1.3× 146 2.4× 97 2.1× 11 465
Cong Sui China 12 142 1.4× 100 1.0× 108 1.2× 59 1.0× 124 2.6× 28 400
J. Hunn United States 7 130 1.3× 136 1.4× 65 0.7× 32 0.5× 22 0.5× 9 367
Fangjie Jiang China 6 185 1.9× 60 0.6× 119 1.3× 34 0.6× 79 1.7× 15 332
Qiuxiao Yu China 6 101 1.0× 103 1.1× 43 0.5× 69 1.1× 56 1.2× 11 301
Maryam Pirhoushiaran Iran 10 82 0.8× 73 0.8× 81 0.9× 61 1.0× 17 0.4× 23 267
Shangren Wang China 9 92 0.9× 42 0.4× 47 0.5× 20 0.3× 30 0.6× 36 255
Luciano Mariani Italy 10 108 1.1× 42 0.4× 58 0.6× 33 0.5× 38 0.8× 15 350
F. M. Wittmaack United States 8 106 1.1× 99 1.0× 41 0.4× 105 1.7× 32 0.7× 11 377

Countries citing papers authored by Cecilia Catellani

Since Specialization
Citations

This map shows the geographic impact of Cecilia Catellani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Catellani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Catellani more than expected).

Fields of papers citing papers by Cecilia Catellani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Catellani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Catellani. The network helps show where Cecilia Catellani may publish in the future.

Co-authorship network of co-authors of Cecilia Catellani

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Catellani. A scholar is included among the top collaborators of Cecilia Catellani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Catellani. Cecilia Catellani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Marvisi, Chiara, et al.. (2025). Biomarkers in ANCA associated vasculitis: clinical utility, pitfalls and their role in the outcomes assessment. Frontiers in Immunology. 16. 1616837–1616837.
2.
Catellani, Cecilia, Martina Bonacini, Alessandro Rossi, et al.. (2025). Glucocorticoid boluses followed by tocilizumab in giant cell arteritis patients: effects on peripheral blood monocytes and lymphocytes. Frontiers in Immunology. 16. 1516008–1516008.
3.
Moghetti, Paolo, Cecilia Catellani, Chiara Sartori, et al.. (2023). Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS. Journal of Endocrinological Investigation. 46(12). 2629–2637. 1 indexed citations
4.
Catellani, Cecilia, Gloria Ravegnini, Chiara Sartori, et al.. (2022). Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months. Frontiers in Endocrinology. 13. 896640–896640. 4 indexed citations
6.
7.
Dauriz, Marco, Francesca Cirillo, Cecilia Catellani, et al.. (2021). Circulating HMGB1 Levels Are Associated With Glucose Clamp-Derived Measures of Insulin Resistance in Women With PCOS. Journal of the Endocrine Society. 5(Supplement_1). A738–A739. 1 indexed citations
8.
Street, Maria Elisabeth, et al.. (2021). Precocious Puberty and Covid-19 Into Perspective: Potential Increased Frequency, Possible Causes, and a Potential Emergency to Be Addressed. Frontiers in Pediatrics. 9. 734899–734899. 36 indexed citations
9.
Catellani, Cecilia, Gloria Ravegnini, Chiara Sartori, Sabrina Angelini, & Maria Elisabeth Street. (2021). GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer. Frontiers in Endocrinology. 12. 701246–701246. 13 indexed citations
10.
Street, Maria Elisabeth, Francesca Cirillo, Cecilia Catellani, et al.. (2020). Current treatment for polycystic ovary syndrome: focus on adolescence. PubMed. 72(4). 288–311. 11 indexed citations
11.
Cirillo, Francesca, Cecilia Catellani, Pietro Lazzeroni, Chiara Sartori, & Maria Elisabeth Street. (2020). The Role of MicroRNAs in Influencing Body Growth and Development. Hormone Research in Paediatrics. 93(1). 7–15. 30 indexed citations
12.
Cirillo, Francesca, Cecilia Catellani, Pietro Lazzeroni, et al.. (2020). HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA). Gynecological Endocrinology. 36(7). 588–593. 28 indexed citations
13.
Cirillo, Francesca, Cecilia Catellani, Pietro Lazzeroni, et al.. (2019). MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity. Frontiers in Endocrinology. 10. 879–879. 60 indexed citations
14.
Cirillo, Francesca, Cecilia Catellani, Chiara Sartori, et al.. (2019). Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play a Role?. International Journal of Molecular Sciences. 20(12). 2922–2922. 63 indexed citations
15.
Cirillo, Francesca, Cecilia Catellani, Chiara Sartori, et al.. (2019). CFTR and FOXO1 gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome. Gynecological Endocrinology. 35(10). 842–846. 21 indexed citations
16.
Cirillo, Francesca, Pietro Lazzeroni, Cecilia Catellani, et al.. (2018). MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance. Cytokine & Growth Factor Reviews. 39. 1–18. 27 indexed citations
17.
Coppi, Gioacchino, et al.. (1983). [Our experience in the therapy of Martorell's hypertensive ulcer].. PubMed. 38(19). 1585–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026